Open-Label Treatment with Desvenlafaxine in Postmenopausal Women with Major Depressive Disorder Not Responding to Acute Treatment with Desvenlafaxine or Escitalopram

Author： Soares Claudio N.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.3, 2011-03, pp. : 227-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Desvenlafaxine succinate for the treatment of major depressive disorder

By Lohoff Falk W   Rickels Karl  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2129-2136

Informa Healthcare

Access to resources Recommend Favorite

Desvenlafaxine delightful in depressive disorder

By  

Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Double-Blind Comparison of Escitalopram and Duloxetine in the Acute Treatment of Major Depressive Disorder

By Khan Arif  

Clinical Drug Investigation, Vol. 27, Iss. 7, 2007-01 ,pp. : 481-492

Adis International

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Escitalopram for the treatment of major depressive disorder in youth

By Ahn Joon-Ho   Patkar Ashwin A  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2235-2244

Informa Healthcare

Access to resources Recommend Favorite